← Scroll for more →
Cullinan Therapeutics, Inc. (CGEM)
Biological Products, (No Diagnostic Substances)
Latest Price
$15.35
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
5.24
P/B Ratio
2.93
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Mpm Bioimpact LLC | 9.73M | $177.0M | 15.12% | +2.08M | 2026-06-30 |
| Lynx1 Capital Management LP | 8.96M | $163.0M | 13.93% | -- | 2026-06-30 |
| Bvf Inc | 5.75M | $104.0M | 8.94% | -- | 2026-06-30 |
| BlackRock, Inc. | 5.23M | $95.0M | 8.13% | +782.8K | 2026-06-30 |
| Price T Rowe Associates Inc | 3.83M | $69.0M | 5.95% | +1.80M | 2026-06-30 |
| State Street Corp | 3.67M | $66.0M | 5.70% | +1.12M | 2026-06-30 |
| Kynam Capital Management, LP | 3.11M | $56.0M | 4.84% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 2.61M | $47.0M | 4.06% | +131.0K | 2026-06-30 |
| Rtw Investments, LP | 2.36M | $43.0M | 3.67% | +658.4K | 2026-06-30 |
| Siren, L.L.C. | 1.89M | $34.0M | 2.94% | +700.0K | 2026-06-30 |